Hyderabad-based Natco Pharma Limited reported a 28.25% rise in consolidated net profit at Rs 26.92 crore during the quarter ended September, 2013, driven by a healthy growth in value-added formulations exports.
The company earned a net profit of Rs 20.99 crore in the corresponding thee month period last year.
There was a 23.9% increase in formulations exports at Rs 96.16 crore as compared with Rs 77.58 crore in the corresponding previous quarter even though total income remained unchanged at Rs 181.20 crore on the back of a fall in revenues from bulk chemicals.
Expenditure almost remained flat (Rs 143.21 crore) as compared with the year ago period of Rs 141.89 crore.
